Literature DB >> 26070835

[Treatment of congenital lacrimal duct obstruction: A prospective clinical cohort study].

J Heichel1, F Bachner2, A Schmidt-Pokrzywniak3, H-G Struck2, U Stuhlträger2, T Bredehorn-Mayr2.   

Abstract

BACKGROUND: Pressurized probing and irrigation is the method of choice for congenital lacrimal duct obstruction after conservative therapeutic strategies have failed. The aim of this study was to evaluate age dependence and success rates of different therapeutic options.
MATERIAL AND METHODS: A prospective cohort study of children with congenital lacrimal duct obstruction was performed. All children treated during the period between May 2009 and June 2010 were included. Surgical success was defined as the absence of epiphora and mucous discharge for a postoperative follow-up of 3 months. Odds ratios (OR) and 95 % confidence intervals (CI) of different variables were estimated using logistic regression.
RESULTS: A total of 111 children (137 eyes) underwent treatment for congenital lacrimal duct obstruction. The mean age of the children was 7.7 months (range 1-30 months). The success rate of probing under local anesthesia was 85.5 % (n = 100). Probing under general anesthesia without intubation of the lacrimal pathway was successful in 28.6 % (n = 2). Treatment under general anesthesia with intubation of the lacrimal pathway had a success rate of 94.2 %. If the primary treatment was complicated the OR was 1.9 (95 % CI: 0.7-5.1), for males the OR was 1.7 (95 % CI: 0.8-3.5) and in cases of a positive family history the OR was 1.5 (95 % CI: 0.7-3.3). With every increasing month of age the risk not to be treated successfully increased (OR: 1.3, 95 % CI: 1.2-1.5).
CONCLUSION: Syringing under local anesthesia is an effective therapy. The highest success rates were found at the ages of 1-6 months. Therapy with additional silicone tube intubation was highly successful.

Entities:  

Keywords:  Epiphora; Lacrimal duct intubation; Lacrimal duct obstruction; Surgery of the lacrimal duct; Syringing and probing

Mesh:

Year:  2015        PMID: 26070835     DOI: 10.1007/s00347-015-0067-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  27 in total

1.  Epiphora during the first year of life.

Authors:  C J MacEwen; J D Young
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

2.  Congenital impatency of the nasolacrimal duct.

Authors:  D GUERRY; E L KENDIG
Journal:  Arch Ophthal       Date:  1948-02

3.  Medical management of congenital nasolacrimal duct obstruction.

Authors:  L B Nelson; J H Calhoun; H Menduke
Journal:  Pediatrics       Date:  1985-08       Impact factor: 7.124

4.  A prospective, randomised comparison of probing versus bicanalicular silastic intubation for congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky; Ahmed Mousa; Hatem Kalantan; Abdullah Al-Otaibi; Hessah Alodan; Adel H Alsuhaibani
Journal:  Br J Ophthalmol       Date:  2014-09-02       Impact factor: 4.638

5.  Outcome of probing for congenital nasolacrimal duct obstruction in older children.

Authors:  S G Honavar; V E Prakash; G N Rao
Journal:  Am J Ophthalmol       Date:  2000-07       Impact factor: 5.258

Review 6.  Management of congenital nasolacrimal duct obstruction.

Authors:  Yasuhiro Takahashi; Hirohiko Kakizaki; Weng O Chan; Dinesh Selva
Journal:  Acta Ophthalmol       Date:  2009-07-21       Impact factor: 3.761

7.  Success rates of nasolacrimal duct probing at time intervals after 1 year of age.

Authors:  R M Robb
Journal:  Ophthalmology       Date:  1998-07       Impact factor: 12.079

8.  Spectrum of pediatric dacryocystitis: medical and surgical management of 54 cases.

Authors:  B N Campolattaro; G T Lueder; L Tychsen
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1997 May-Jun       Impact factor: 1.402

9.  Success rate of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Semi Perveen; Aalia Rasool Sufi; Sabia Rashid; Afroz Khan
Journal:  J Ophthalmic Vis Res       Date:  2014-01

10.  Risk factors for developing congenital nasolacrimal duct obstruction.

Authors:  Faisal D Aldahash; Muhammad F Al-Mubarak; Saad H Alenizi; Yasser H Al-Faky
Journal:  Saudi J Ophthalmol       Date:  2013-10-10
View more
  4 in total

1.  [Increased prevalence of congenital dacryostenosis following cesarean section].

Authors:  Claudia Kuhli-Hattenbach; M Lüchtenberg; C Hofmann; T Kohnen
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

Review 2.  [Congenital nasolacrimal duct obstruction from an ophthalmologist's point of view : Causes, diagnosis and staged therapeutic concept].

Authors:  J Heichel; T Bredehorn-Mayr; H-G Struck
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

Review 3.  [Minimally invasive diagnostics and therapy of congenital nasolacrimal duct obstruction].

Authors:  J Heichel; H-G Struck
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

4.  [Medical and psychological aspects of the treatment of connatal dacryostenosis : Parental evaluation of their own and their child's stress].

Authors:  J Heichel; F Bachner; G Hübner; H-G Struck; T Bredehorn-Mayr
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.